250 related articles for article (PubMed ID: 9634306)
1. Analysis of quinolone resistance mechanisms in Neisseria gonorrhoeae isolates in vitro.
Tanaka M; Sakuma S; Takahashi K; Nagahuzi T; Saika T; Kobayashi I; Kumazawa J
Sex Transm Infect; 1998 Feb; 74(1):59-62. PubMed ID: 9634306
[TBL] [Abstract][Full Text] [Related]
2. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
Yasuda M; Fukuda H; Yokoi S; Ishihara S; Kawada Y; Deguchi T
J Urol; 2000 Sep; 164(3 Pt 1):847-51. PubMed ID: 10953166
[TBL] [Abstract][Full Text] [Related]
3. Development of fluoroquinolone resistance and mutations involving GyrA and ParC proteins among Neisseria gonorrhoeae isolates in Japan.
Tanaka M; Takahashi K; Saika T; Kobayashi I; Ueno T; Kumazawa J
J Urol; 1998 Jun; 159(6):2215-9. PubMed ID: 9598572
[TBL] [Abstract][Full Text] [Related]
4. Mutation in DNA gyrase of norfloxacin-resistant clinical isolates of Neisseria gonorrhoeae.
Tanaka M; Otsuki M; Nishino T; Kobayashi I; Matsumoto T; Kumazawa J
Genitourin Med; 1996 Aug; 72(4):295-7. PubMed ID: 8976839
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998.
Su X; Lind I
Antimicrob Agents Chemother; 2001 Jan; 45(1):117-23. PubMed ID: 11120953
[TBL] [Abstract][Full Text] [Related]
6. gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Kenya.
Kivata MW; Mbuchi M; Eyase FL; Bulimo WD; Kyanya CK; Oundo V; Muriithi SW; Andagalu B; Mbinda WM; Soge OO; McClelland RS; Sang W; Mancuso JD
BMC Microbiol; 2019 Apr; 19(1):76. PubMed ID: 30961546
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 91 clinical isolates of Neisseria gonorrhoeae in Japan.
Shigemura K; Shirakawa T; Okada H; Hinata N; Acharya B; Kinoshita S; Kofuku T; Kawabata M; Kamidono S; Arakawa S; Gotoh A
Sex Transm Dis; 2004 Mar; 31(3):180-4. PubMed ID: 15076932
[TBL] [Abstract][Full Text] [Related]
8. Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC.
Shultz TR; Tapsall JW; White PA
Antimicrob Agents Chemother; 2001 Mar; 45(3):734-8. PubMed ID: 11181352
[TBL] [Abstract][Full Text] [Related]
9. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
[TBL] [Abstract][Full Text] [Related]
10. Analysis of quinolone resistance mechanisms in a sparfloxacin-resistant clinical isolate of Neisseria gonorrhoeae.
Tanaka M; Nakayama H; Haraoka M; Nagafuji T; Saika T; Kobayashi I
Sex Transm Dis; 1998 Oct; 25(9):489-93. PubMed ID: 9800262
[TBL] [Abstract][Full Text] [Related]
11. Reduced clinical efficacy of pazufloxacin against gonorrhea due to high prevalence of quinolone-resistant isolates with the GyrA mutation. The Pazufloxacin STD Group.
Tanaka M; Matsumoto T; Sakumoto M; Takahashi K; Saika T; Kabayashi I; Kumazawa J
Antimicrob Agents Chemother; 1998 Mar; 42(3):579-82. PubMed ID: 9517935
[TBL] [Abstract][Full Text] [Related]
12. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates.
Belland RJ; Morrison SG; Ison C; Huang WM
Mol Microbiol; 1994 Oct; 14(2):371-80. PubMed ID: 7830580
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of a new fluoroquinolone, DU-6859a, against quinolone-resistant clinical isolates of Neisseria gonorrhoeae with genetic alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV.
Deguchi T; Yasuda M; Nakano M; Kanematsu E; Ozeki S; Ishihara S; Saito I; Kawada Y
J Antimicrob Chemother; 1997 Feb; 39(2):247-9. PubMed ID: 9069547
[TBL] [Abstract][Full Text] [Related]
14. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa.
Jalal S; Wretlind B
Microb Drug Resist; 1998; 4(4):257-61. PubMed ID: 9988043
[TBL] [Abstract][Full Text] [Related]
16. Mutation patterns in gyrA and parC genes of ciprofloxacin resistant isolates of Neisseria gonorrhoeae from India.
Chaudhry U; Ray K; Bala M; Saluja D
Sex Transm Infect; 2002 Dec; 78(6):440-4. PubMed ID: 12473806
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the gyrA and parC genes of quinolone-resistant Neisseria gonorrhoeae isolates in India.
Kulkarni S; Bala M; Sane S; Pandey S; Bhattacharya J; Risbud A
Int J Antimicrob Agents; 2012 Dec; 40(6):549-53. PubMed ID: 23063097
[TBL] [Abstract][Full Text] [Related]
18. Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles.
Deguchi T; Yasuda M; Nakano M; Ozeki S; Ezaki T; Saito I; Kawada Y
Antimicrob Agents Chemother; 1996 Apr; 40(4):1020-3. PubMed ID: 8849219
[TBL] [Abstract][Full Text] [Related]
19. Mutations in gyrA, gyrB, parC, and parE in quinolone-resistant strains of Neisseria gonorrhoeae.
Lindbäck E; Rahman M; Jalal S; Wretlind B
APMIS; 2002 Sep; 110(9):651-7. PubMed ID: 12529019
[TBL] [Abstract][Full Text] [Related]
20. High-frequency of quinolone-resistant Neisseria gonorrhoeae in Austria with a common pattern of triple mutations in GyrA and ParC genes.
Uthman A; Heller-Vitouch C; Stary A; Bilina A; Kuchinka-Koch A; Söltz-Szöts J; Tschachler E
Sex Transm Dis; 2004 Oct; 31(10):616-8. PubMed ID: 15389000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
